Our study complements existing knowledge by showing that circulating iNKT cells from obese and obese/T2D patients are impaired in their ability to secrete IL-2, IFN-γ, and to a lesser extent IL-4. This evidence concerns the gene IFNG and type 2 diabetes mellitus.